Our Long Non-coding RNA (LncRNA) Research services support biotechnology teams, pharmaceutical research groups, academic laboratories, and functional genomics programs that need to move from an lncRNA candidate to a testable biological mechanism. LncRNAs are commonly grouped as RNA transcripts longer than about 200 nucleotides with limited or no established protein-coding potential, but their research value depends on much more than transcript length. Isoform identity, genomic context, abundance, subcellular localization, RNA structure, and interaction partners can all influence how a candidate should be studied.
Our service framework connects lncRNA discovery and expression profiling with transcript validation, localization, perturbation, interaction mapping, and functional follow-up. Rather than applying the same assay sequence to every target, we help researchers choose methods according to whether the central question concerns the RNA molecule itself, the act of transcription, the underlying genomic locus, or an RNA-mediated interaction network. This question-led approach is designed to generate interpretable data and reduce the risk of pursuing a mechanistic model that the experimental design cannot distinguish.
Figure 1. LncRNA classification according to their orientation and position in the genome. (G, Latgé.; et al, 2018)
Transcript Identity & Isoform Ambiguity: A differential-expression signal does not always define the exact lncRNA species responsible for a phenotype. Alternative start sites, splice forms, antisense transcription, and incomplete annotations can complicate primer, probe, and perturbation design. We support targeted transcript confirmation, boundary mapping, splice-junction validation, and isoform-aware assay planning before downstream functional work.
Low Abundance & Strand-Specific Detection: Many lncRNAs are expressed at lower levels than abundant coding transcripts, and antisense or overlapping transcription can create assignment problems. We help align RNA quality control, ribosomal RNA depletion, strand-aware profiling, targeted RT-qPCR, and replicate strategy with the abundance and genomic architecture of the target so that candidate selection is based on interpretable signal.
Localization-Dependent Method Choice: Nuclear, chromatin-associated, and cytoplasmic lncRNAs often require different perturbation and interaction strategies. Subcellular fractionation and RNA FISH can therefore be decision-making assays rather than descriptive endpoints. Localization data can guide whether an ASO, RNAi approach, CRISPR-based transcriptional perturbation, or compartment-specific interaction assay is the more informative next step.
RNA Function vs. Locus Function: Repressing a lncRNA promoter, degrading its transcript, deleting genomic sequence, and overexpressing a cDNA do not test the same biological hypothesis. We design comparison and rescue strategies that help distinguish effects caused by the RNA product from effects linked to local DNA elements or transcription through the locus, reducing overinterpretation of a single perturbation result.
Interaction Evidence & Mechanistic Confidence: Predicted lncRNA-protein, lncRNA-chromatin, or lncRNA-RNA relationships are useful for prioritization but are not sufficient to establish mechanism. We combine hypothesis-driven capture assays, appropriate negative controls, reciprocal or orthogonal confirmation, and downstream functional readouts so that interaction data can be connected to a reproducible biological effect.
Our lncRNA research services can be used as a complete discovery-to-validation program or as focused modules for an existing project. The recommended scope depends on whether you are starting with raw samples, an RNA-seq candidate list, a published lncRNA, a defined interaction hypothesis, or an unresolved functional phenotype.
Projects are planned around explicit decision points: confirm the transcript, establish where it is expressed, select a perturbation that matches the biological question, identify candidate partners or genomic targets, and validate the mechanism with independent evidence. This keeps sequencing, molecular biology, and functional assays connected to the same research hypothesis.
LncRNA experimental design should account for transcript-specific features that can directly affect detection, perturbation efficiency, interaction analysis, and interpretation of functional results. Evaluating these factors before selecting assays helps reduce method mismatch, distinguish RNA-dependent effects from locus-associated effects, and build a more reliable validation strategy.
| LncRNA Feature | Why It Matters | Experimental Consideration | Potential Risk |
| Low Transcript Abundance | Low expression can reduce detection sensitivity and increase variability across biological replicates. | Confirm target expression before complex downstream studies and optimize RNA input, detection method, primer design, and replicate strategy according to expected abundance. | Weak signal may lead to false-negative results, unstable quantification, or inefficient downstream interaction assays. |
| Nuclear Localization | Nuclear and chromatin-associated lncRNAs may not be efficiently depleted by approaches optimized for cytoplasmic RNA. | Consider transcript-directed ASO approaches, transcriptional perturbation, subcellular fractionation, RNA FISH, or nuclear interaction assays according to the research question. | An unsuitable perturbation strategy can produce limited knockdown and misleading conclusions about target function. |
| Cytoplasmic Localization | Cytoplasmic distribution can influence both perturbation strategy and the types of RNA-protein or RNA-RNA interactions that are practical to investigate. | Evaluate RNAi-compatible depletion, cytoplasmic fractionation, targeted interaction assays, and downstream gene-expression or pathway readouts. | Assuming localization without experimental confirmation may direct the project toward inappropriate functional assays. |
| Multiple Isoforms | Alternative promoters, splice patterns, or transcript ends can generate isoforms with different abundance, localization, or biological activity. | Define relevant isoforms and use isoform-specific primers, probes, targeting reagents, or expression constructs when the biological question requires transcript-level resolution. | Non-selective detection or perturbation may combine several isoforms and obscure which transcript species contributes to the observed phenotype. |
| Antisense or Overlapping Transcription | LncRNA loci can overlap coding genes or other non-coding transcripts on the same or opposite strand. | Use strand-aware detection, carefully positioned primers and probes, and targeting sequences that minimize unintended effects on overlapping transcripts. | Cross-detection or collateral perturbation can make it difficult to attribute an observed effect specifically to the intended lncRNA. |
| Nearby Coding Genes | Some lncRNA loci can influence neighboring gene expression through local DNA elements or the process of transcription rather than through the mature RNA alone. | Compare transcript-directed depletion with transcriptional perturbation or other complementary approaches and monitor nearby gene expression during functional studies. | A local genomic or transcriptional effect may be incorrectly interpreted as evidence that the mature lncRNA molecule is directly responsible. |
| Complex Transcript Structure | Incomplete annotation, alternative transcription start sites, splice junctions, or uncertain transcript ends can affect every downstream reagent design. | Confirm transcript boundaries and key splice forms using targeted amplification, junction analysis, RACE, or sequence verification before designing functional constructs or capture reagents. | An incorrect transcript model can compromise primers, FISH probes, ASOs, pull-down constructs, and overexpression studies. |
| RNA Secondary Structure | Local RNA structure can affect hybridization accessibility and may influence interactions with proteins, nucleic acids, or capture probes. | Consider accessible sequence regions when designing probes, ASOs, capture oligonucleotides, pull-down fragments, or truncation constructs. | Poorly accessible target regions can reduce hybridization efficiency or cause an experimental construct to behave differently from the native transcript. |
| Chromatin Association | Chromatin-associated lncRNAs may act near their transcription site or associate with more distant genomic regions. | Integrate localization data with chromatin-capture approaches and downstream expression analysis to test whether physical association is linked to regulatory effects. | Detection of chromatin association alone may be overinterpreted as evidence of direct gene regulation. |
| Condition-Specific Expression | LncRNA abundance can vary substantially with cell type, differentiation state, stimulus, culture condition, or experimental time point. | Confirm target expression in the exact experimental model and condition before initiating perturbation, localization, or interaction studies. | Results obtained in one model or condition may not reproduce when the lncRNA is absent, weakly expressed, or regulated differently elsewhere. |
Perturbation method is one of the most important choices in lncRNA functional analysis because different tools act on different biological layers. The table below summarizes how commonly used approaches can be matched to target localization, locus context, and the question being tested.
| Perturbation Method | Best-Fit Question | Primary Level Perturbed | Useful Features | Key Interpretation Considerations |
| RNase H-active ASO / GapmeR | Is the mature or nascent lncRNA transcript required? | RNA transcript through sequence-directed degradation | Often useful for nuclear or chromatin-associated targets; does not require genomic cutting | Target accessibility, isoform coverage, sequence-specific effects, and multiple independent oligos should be considered |
| siRNA / shRNA | Does depletion of an accessible lncRNA change the selected readout? | RNA transcript through RNAi machinery | Well suited to many cytoplasmic targets and compatible with transient or longer-term knockdown formats | Nuclear accessibility can be limiting; confirm depletion and use independent targeting sequences |
| CRISPRi | Does reducing endogenous transcription from the lncRNA locus alter the phenotype? | Transcription initiation or promoter activity | Maintains the native genomic locus while reducing transcription without introducing a double-strand break | Effects may reflect transcriptional or local regulatory changes rather than loss of the RNA molecule alone |
| CRISPRa | Does increased endogenous transcription reveal a functional effect? | Transcriptional activation at the native locus | Preserves endogenous transcript processing and local genomic context more closely than ectopic cDNA expression | Neighboring regulatory effects and baseline expression should be reviewed before assigning RNA-specific causality |
| Ectopic Overexpression | Is the transcript sufficient to produce a trans-acting effect? | RNA abundance from an exogenous construct | Flexible for isoform, truncation, motif, and rescue experiments | Expression level, transcript processing, localization, and inability to reproduce cis-locus effects can complicate interpretation |
A useful lncRNA workflow is not simply a sequence of assays. Each stage should resolve a defined uncertainty before the project advances to more expensive or more mechanistically specific experiments. Our process is organized around that principle.
We define the biological question, experimental model, candidate status, available datasets, and desired endpoints. This establishes whether the project begins with discovery, transcript confirmation, functional perturbation, or a specific interaction hypothesis and prevents unrelated assays from being added without a decision purpose.
Candidate annotation, isoforms, neighboring genes, strand orientation, expected abundance, localization evidence, and sequence uniqueness are reviewed. We then identify design risks involving primers, probes, targeting reagents, capture oligos, or expression constructs before experimental work begins.
The study plan is matched to the hypothesis, with biological replicates, negative controls, independent perturbation reagents, compartment markers, capture controls, and rescue logic defined where applicable. Deliverables and go/no-go criteria are agreed at the same stage so the resulting data can support a clear next decision.
We perform the agreed profiling, validation, localization, perturbation, or interaction assays with fit-for-purpose quality checks. Key assay milestones—such as transcript detection, knockdown efficiency, fraction quality, probe specificity, or enrichment over controls—are reviewed before downstream interpretation.
High-priority findings are tested using an independent method or complementary readout when feasible. Examples include reciprocal interaction assays, rescue experiments, secondary targeting reagents, localization-aware follow-up, or expression testing of candidate downstream genes to strengthen the proposed mechanism.
Results are integrated across transcript identity, expression, localization, perturbation, and interaction data. The final package separates direct observations from interpretation, summarizes technical limitations, identifies unresolved alternatives, and provides practical recommendations for the next research stage.
LncRNA projects are especially vulnerable to method mismatch because the transcript, the act of transcription, and the genomic locus can contribute different effects. Our service model emphasizes experimental logic and cross-method consistency so that each result can be interpreted in the context of the question it was designed to answer.
Long non-coding RNA research spans transcript discovery, gene-regulatory mechanism studies, chromatin biology, RNA interaction networks, and phenotype-driven functional genomics. Our modular service framework can be adapted to targeted single-lncRNA studies or broader candidate-prioritization programs.
If you already have an lncRNA candidate, we can help define the shortest experimental path from transcript confirmation to functional evidence. If you are starting from RNA samples or a broad transcriptomic dataset, we can support candidate discovery, ranking, and stepwise validation before committing resources to deeper interaction or mechanism studies. Share your target, species, experimental model, available sequence or expression data, and the biological question you want to resolve. Contact us to discuss an lncRNA research plan aligned with your current project stage and decision needs.
Non-coding RNA (ncRNA) refers to a class of RNA molecules transcribed from DNA but not encoding proteins. Non-coding RNAs can be classified into different categories based on their size, structure, and function. Some well-known types of non-coding RNAs include transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). Each type of non-coding RNA plays specific roles in processes such as translation, RNA processing, gene regulation, chromatin modification, and cellular signaling.
RNA is a broad class of molecules that includes both coding and non-coding types. Non-coding RNA is a class of RNA molecules that are not translated into proteins. Coding RNAs, on the other hand, carry genetic information from DNA to ribosomes where it is translated into proteins.
Yes, most long non-coding RNAs are polyadenylated, with a polyadenine (poly A) tail at their 3' end. Poly A structures are a common feature of RNA processing in eukaryotic cells, and are associated with RNA molecule stability and regulation. However, not all lncRNAs have polyadenylate tails. Some functional lncRNAs do not have polyadenylate tails, which affects the stability, localization, and function of these lncRNAs in the cell.
Loading ......
